Photocure ASA: Renewal of market maker agreement

Share this article
Published: 26 May 2015Financial Investment & Stock

Oslo, Norway, 26 May 2015: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces that its market maker agreement with DNB Markets will be replaced with a similar market maker agreement with Norne Securities with effect as of 1 August 2015.

For further information, please contact:

Photocure
CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.no

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)
Share this article

News and events